Purple Innovation, Inc. (PRPL): Nasdaq/NYSE listing notice — Purple Innovation receives Nasdaq deficiency notice for bid price below $1.00

Purple Innovation, Inc.

Received Nasdaq notice on April 4, 2025 for non-compliance with minimum bid price rule 5450(a)(1).
Closing bid price below $1.00 per share for 30 consecutive business days triggered the notice.
Company has 180 calendar days, until October 1, 2025, to regain compliance with a $1.00 minimum bid for 10 consecutive days.
If not cured, may transfer to Nasdaq Capital Market for an additional 180-day period, subject to other listing standards.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Purple Innovation, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

April 4, 2025, Purple Innovation, Inc. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1), as the closing bid price of the Company’s common stock has been below the required minimum of $1.00 per share for 30 consecutive business days. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s Class A common stock on The Nasdaq Global Select Market. The Company has 180 calendar days, or until October 1, 2025, to

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Purple Innovation, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-029408

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.